Zeller-Gerten LIFE Poster - Electronic Cochlear Implant Minimum Speech Test Battery (MSTB-3) Forms
Product Description:
Multichannel cochlear implants were approved by the FDA in 1984 and are widely used as a treatment option for severe to profound hearing loss. A speech testing protocol called the Minimum Speech Test Battery (MSTB) was first developed in 1996 to determine cochlear implant eligibility and to monitor benefit. The MSTB was revised (MSTB-3) in 2022 addressed changes to cochlear implant candidacy requirements to included people with better low frequency hearing and single sided deafness.
Keyword(s):
cochlear implant, speech test, hearing, LEND
Product/Publication Type(s):
Conference presentations and posters presented
Target Audience:
Consumers/Families, Professionals, Policymakers, Students
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A